Compass Therapeutics Price Target Announced at $32.00/Share by D. Boral Capital
Compass Point Initiates Coverage On NCR Atleos With Buy Rating, Announces Price Target of $57
Compass Point Downgrades Innovative Ind Props to Neutral, Lowers Price Target to $78
Compass Point Adjusts Price Target on American Express to $325 From $315, Keeps Neutral Rating
Compass Minerals Intl Analyst Ratings
BMO Capital Maintains Market Perform on Compass Minerals Intl, Lowers Price Target to $18
Iris Energy (IREN) Receives a Buy From Compass Point
Needham Maintains Compass(COMP.US) With Buy Rating, Raises Target Price to $10
Compass Point Maintains Buy on FTAI Aviation, Raises Price Target to $181
Compass Point Upgrades Horizon Tech Finance to Neutral, Announces $8.25 Price Target
Boston Properties (BXP) Gets a Buy From Compass Point
Compass Is Maintained at Equal-Weight by Barclays
Compass Analyst Ratings
Barclays Maintains Compass(COMP.US) With Hold Rating, Raises Target Price to $7
Wells Fargo Is Maintained at Neutral by Compass Point
Wells Fargo Price Target Raised to $83.00/Share From $60.00 by Compass Point
Citizens Financial Group Price Target Raised to $57.00/Share From $45.00 by Compass Point
Citizens Financial Group Is Maintained at Buy by Compass Point
Compass Point Maintains Buy on BankUnited, Raises Price Target to $49
Compass Point Adjusts Price Target on American Express to $315 From $260, Maintains Neutral